Stable pulmonary function after haploidentical stem cell transplantation with post-transplant cyclophosphamide: a single center experience

被引：0

作者：

Paviglianiti, Annalisa ^{[1
,2
]}

Sestili, Simona ^{[1
]}

Bianchessi, Antonio ^{[1
,3
,4
]}

Memoli, Mara ^{[1
,5
]}

Dulery, Remy ^{[1
]}

Banet, Anne ^{[1
]}

Van De Wyngaert, Zoe ^{[1
]}

Belhocine, Ramdane ^{[1
]}

Ledraa, Tounes ^{[1
]}

Malard, Florent ^{[1
]}

Mohty, Mohamad ^{[1
]}

Brissot, Eolia ^{[1
]}

机构：

[1] Sorbonne Univ, Serv Hematol Clin & Therapie Cellulaire, Hop St Antoine, 184 Rue Faubourg St Antoine, F-75012 Paris, France

[2] Univ Campus Biomed, Rome, Italy

[3] Univ Pavia, Dept Mol Med, Pavia, Italy

[4] Fdn IRCCS Policlin San Matteo, Div Hematol, Pavia, Italy

[5] Univ Naples Federico II, Hematol & Hematopoiet Stem Cell Transplant Ctr, Dept Med & Surg, Naples, Italy

来源：

LEUKEMIA & LYMPHOMA | 2022年 / 63卷 / 02期

关键词：

PFT; HAPLO; pulmonary function; pulmonary function tests; HSCT; lung function score; BRONCHIOLITIS-OBLITERANS; LUNG-FUNCTION; COMPLICATIONS; DISEASE; ABNORMALITIES; MORTALITY; PREVENTS; INDEX;

D O I：

10.1080/10428194.2021.1984460

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Prior studies have reported pulmonary function tests (PFT) before and after related and unrelated allogeneic hematopoietic stem cell transplantation (HSCT). However, limited data exist on the evaluation of lung function after haploidentical stem cell transplantation (HAPLO) with post-transplant cyclophosphamide (PTCY). We retrospectively reported the evaluation of PFTs at screening before HAPLO in 80 patients at 100 days and 1 year of follow-up. The proportion of surviving patients with available PFTs at 100 days and 1 year were 86% and 68%, respectively. During the follow-up period, four patients met the criteria for bronchiolitis obliterans syndrome and two for interstitial lung disease. Overall survival was 73% (95% CI 62-82%) at 2 years. We observed a significant reduction in diffusing capacity of the lungs for carbon monoxide (DLCO) corrected for the most recent hemoglobin concentration (DLCOc) at 100 days after HAPLO. However, an overall substantial stable pulmonary function was observed at 1 year.

引用

页码：443 / 449

页数：7

共 50 条

[1] Stable Pulmonary Function after Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide: A Single Center Experience
Paviglianiti, Annalisa
Sestili, Simona
Bianchessi, Antonio
Brissot, Eolia
Memoli, Mara
Dulery, Remy
Banet, Anne
Van de Wyngaert, Zoe
Belhocine, Ramdane
Ledraa, Tounes
Malard, Florent
Mohty, Mohamad
[J]. BLOOD, 2020, 136
[2] Haploidentical stem cell transplantation with post-transplant HD-cyclophosphamide in children-single center experience
Bazaluk, J.
Ryzhak, O.
Kovgan, Y.
Kavardakova, N.
Lysitsia, A.
Matsibokh, S.
Leontieva, O.
Zinchuk, A.
Kreminskaya, E.
Ponomarenko, T.
Smolenskaya, T.
Sharomok, A.
Donska, S.
[J]. BONE MARROW TRANSPLANTATION, 2017, 52 : S361 - S362
[3] Poor graft function after haploidentical stem cell transplantation with post-transplant cyclophosphamide
Gomez-Centurion, Ignacio
Rojas, Reyes Maria Martin
Bailen, Rebeca
Munoz, Cristina
Sabell, Santiago
Oarbeascoa, Gillen
Fernandez-Caldas, Paula
Carbonell, Diego
Gayoso, Jorge
Martinez-Laperche, Carolina
Buno, Ismael
Anguita, Javier
Diez-Martin, Jose Luis
Kwon, Mi
[J]. ANNALS OF HEMATOLOGY, 2023, 102 (06) : 1561 - 1567
[4] Poor graft function after haploidentical stem cell transplantation with post-transplant cyclophosphamide
Ignacio Gómez-Centurión
Reyes Maria Martin Rojas
Rebeca Bailén
Cristina Muñoz
Santiago Sabell
Gillen Oarbeascoa
Paula Fernández-Caldas
Diego Carbonell
Jorge Gayoso
Carolina Martínez-Laperche
Ismael Buño
Javier Anguita
José Luis Díez-Martin
Mi Kwon
[J]. Annals of Hematology, 2023, 102 : 1561 - 1567
[5] Improving Outcomes with Haploidentical Stem Cell Transplantation [HaploSCT] in Children Using Post-transplant Cyclophosphamide: a Single Center Experience
George, Biju
Kulkarni, Uday
Lionel, Sharon
Devasia, Anup J.
Aboobacker, Fouzia N.
Lakshmi, Kavitha M.
Selvarajan, Sushil
Korula, Anu
Abraham, Aby
Mathews, Vikram
[J]. INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2024, 40 (03) : 375 - 384
[6] Engraftment syndrome after haploidentical stem cell TRANSPLANTATION with post-transplant cyclophosphamide
Landete, Elena
Solan, Laura
Bailen, Rebeca
Dorado, Nieves
Balsalobre, Pascual
Martinez-Laperche, Carolina
Anguita, Javier
Luis Diez-Martin, Jose
Kwon, Mi
[J]. BONE MARROW TRANSPLANTATION, 2019, 54 : 68 - 69
[7] Haploidentical Stem Cell transplantation with Post-Transplant Cyclochosphamide in children: prolonged single center experience
Bazaluk, Julia
Ryzhak, Oleg
Kovgan, Yana
Kavardakova, Natalia
Matsibokh, Sophia
Leontyeva, Oxana
Zinchuk, Alyona
Kireiev, Igor
Kreminska, Olena
Ponomarenko, Tatyana
Smolenska, Tamara
Sharamok, Olexandra
Donska, Svitlana
[J]. BONE MARROW TRANSPLANTATION, 2018, 53 : 699 - 700
[8] Donor's age influences outcome in haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide - a single center experience
Zielinska, Patrycja
Wieczorkiewicz-Kabut, Agata
Bialas, Krzysztof
Koclega, Anna
Gruenpeter, Karolina
Kopinska, Anna
Wozniczka, Krzysztof
Noster, Izabela
Gromek, Tomasz
Czyz, Jaroslaw
Grosicki, Sebastian
Wierzbowska, Agnieszka
Krzanowski, Jacek
Butrym, Aleksandra
Helbig, Grzegorz
[J]. ANNALS OF HEMATOLOGY, 2024, 103 (08) : 3095 - 3104
[9] Infections Post Haploidentical Transplant using Post-Transplant Cyclophosphamide Single Center Experience
Ghatasheh, L.
Sultan, I.
Rihani, R.
Hashem, H.
Abu-Shanap, M.
Khattab, E.
[J]. PEDIATRIC BLOOD & CANCER, 2021, 68 : S207 - S208
[10] Experience on Haploidentical Stem Cell Transplantation With Post-transplant Cyclophosphamide for Children With Hematological Malignancies
Tsujimoto, Shinichi
Osumi, Tomoo
Sakamoto, Kenichi
Isshiki, Kyohei
Mizuno, Takanori
Uchiyama, Meri
Sugawa, Masahiro
Matsukawa, Yukihiro
Shioda, Yoko
Kiyotani, Chikako
Terashima, Keita
Uchiyama, Toru
Deguchi, Takao
Tomizawa, Daisuke
Kato, Motohiro
Matsumoto, Kimikazu
[J]. PEDIATRIC BLOOD & CANCER, 2019, 66 : S93 - S93

← 1 2 3 4 5 →